Clinical Trial Update: CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update for a keratinocyte carcinoma chemoprevention study (VA CSP #562) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Carcinoma
• Skin Diseases
• Skin Neoplasms
• Squamous Cell Carcinoma

Snippet

Sponsor: VA Office of Research and Development | Conditions: Carcinoma, Basal Cell, Carcinoma, Squamous Cell | Phase 4 | Status: COMPLETED | Results posted: 2017-03-17